ChemoCentryx Competitors and Similar CompaniesClear all
ChemoCentryx's competitors and similar companies include Agios Pharmaceuticals and Turning Point Therapeutics.
 ChemoCentryx ChemoCentryx is a biopharmaceutical company commercializing and developing medications for inflammatory and autoimmune diseases and cancer. |  Agios Pharmaceuticals Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism. |  Turning Point Therapeutics Turning Point Therapeutics (TP Therapeutics) is a precision oncology company that is engaged in medicine discovery for cancer and other diseases. | |
Founding Date | Founding Date 1997 | Founding Date 2008 | Founding Date 2013 |
Type | Type Subsidiary | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations San Carlos, US HQ | Locations Cambridge, US HQ | Locations San Diego, US HQ |
Employees | Employees 51 | Employees 53611% increase | Employees 474% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) $32.2m (FY, 2021) | Revenue (est.) $54m (FY, 2025) | Revenue (est.) $30.8m (FY, 2021) |
Cost of goods | Cost of goods $302k (FY, 2021) | Cost of goods $6.3m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $31.9m (FY, 2021) | Gross profit $47.7m (FY, 2025) | Gross profit N/A |
Net income | Net income ($131.8m) (FY, 2021) | Net income ($412.8m) (FY, 2025) | Net income ($236.6m) (FY, 2021) |
Funding | |||
Total funding raised | Total funding raised $ 149.5m | Total funding raised N/A | Total funding raised $ 144.4m |
For sources of this data, please see the company profile
View Company Profiles
Agios Pharmaceuticals
HQ
Cambridge, US
Employees
536↑ 11% increase
Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism.
View companyTurning Point Therapeutics
HQ
San Diego, US
Turning Point Therapeutics (TP Therapeutics) is a precision oncology company that is engaged in medicine discovery for cancer and other diseases.
View company